Zoetis (ZTS) Depreciation & Amortization (CF) (2012 - 2026)
Zoetis (ZTS) reported Depreciation & Amortization (CF) of $119.0 million for Q1 2026, little changed year-over-year from $119.0 million in Q1 2025, and down 1.65% quarter-over-quarter from $121.0 million in Q4 2025.
Zoetis (ZTS) Depreciation & Amortization (CF) (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Depreciation & Amortization (CF) data on file, last reported at $119.0 million in Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $119.0 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $487.0 million (down 0.61% YoY), and the FY2025 annual result was $487.0 million, down 2.01% from the prior year.
- Depreciation & Amortization (CF) slipped to $119.0 million in Q1 2026 per ZTS's latest filing, from $121.0 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $127.0 million in Q2 2024 and troughed at $114.0 million in Q1 2022.
- A 5-year average of $121.1 million and a median of $121.0 million in 2023 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2023 and 2025: Depreciation & Amortization (CF) advanced 7.83% in 2023, then dropped 5.56% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $119.0 million in 2022, then gained by 5.88% to $126.0 million in 2023, then dropped by 2.38% to $123.0 million in 2024, then decreased by 1.63% to $121.0 million in 2025, then dropped by 1.65% to $119.0 million in 2026.
- Business Quant data shows ZTS's Depreciation & Amortization (CF) at $119.0 million in Q1 2026, $121.0 million in Q4 2025, and $124.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 22.68 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 21.95 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 497,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 119.00 Mn |
| Mar 31, 2026 | 119.00 Mn |
| Dec 31, 2025 | 121.00 Mn |
| Dec 31, 2025 | 121.00 Mn |
| Sep 30, 2025 | 124.00 Mn |
| Sep 30, 2025 | 124.00 Mn |
| Jun 30, 2025 | 123.00 Mn |
| Jun 30, 2025 | 123.00 Mn |
| Mar 31, 2025 | 119.00 Mn |
| Mar 31, 2025 | 119.00 Mn |
| Dec 31, 2024 | 123.00 Mn |
| Dec 31, 2024 | 123.00 Mn |
| Sep 30, 2024 | 121.00 Mn |
| Sep 30, 2024 | 121.00 Mn |
| Jun 30, 2024 | 127.00 Mn |
| Jun 30, 2024 | 127.00 Mn |
| Mar 31, 2024 | 126.00 Mn |
| Mar 31, 2024 | 126.00 Mn |
| Dec 31, 2023 | 126.00 Mn |
| Dec 31, 2023 | 126.00 Mn |